ID: ALA5287396

Max Phase: Preclinical

Molecular Formula: C11H12N2O6

Molecular Weight: 268.23

Associated Items:

Representations

Canonical SMILES:  COc1ccc(NC(=O)CCC(=O)O)c([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C11H12N2O6/c1-19-7-2-3-8(9(6-7)13(17)18)12-10(14)4-5-11(15)16/h2-3,6H,4-5H2,1H3,(H,12,14)(H,15,16)

Standard InChI Key:  DBBWQXIPXFGNTL-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania major 2877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 268.23Molecular Weight (Monoisotopic): 268.0695AlogP: 1.41#Rotatable Bonds: 6
Polar Surface Area: 118.77Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.13CX Basic pKa: CX LogP: 0.82CX LogD: -2.64
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.59Np Likeness Score: -1.34

References

1. Kapil S, Singh PK, Silakari O..  (2018)  An update on small molecule strategies targeting leishmaniasis.,  157  [PMID:30099256] [10.1016/j.ejmech.2018.08.012]

Source